Chicago, Illinois, United States The main office of represented VC is situated in the Chicago. The venture was found in North America in United States.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Semiconductor, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight CytoPherx, Viamet Pharmaceuticals, Cernium. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups.
We also calculated 1 valuable employee in our database.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Lurie Investment Fund, startups are often financed by Ardesta, Partech, 3i Group. The meaningful sponsors for the fund in investment in the same round are Apjohn ventures, North Coast Technology Investors, Deutsche Bank. In the next rounds fund is usually obtained by Apjohn ventures, Scale Venture Partners, QVT Financial.
The fund is constantly included in less than 2 deals per year. When the investment is from Lurie Investment Fund the average startup value is 50-100 millions dollars. The top amount of exits for fund were in 2007. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2007. This Lurie Investment Fund works on 9 percentage points more the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 24 percentage points more often commits exit comparing to other organizations.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Ankang Venture Investment | - |
| Barclays Investment Bank | Atlanta, Georgia, United States |
| BD Ventures | Bangladesh, Dhaka, Dhaka Division |
| Gandyr Group | Herzliya, Israel, Tel Aviv |
| Hambrecht & Quist Capital Management | Boston, Massachusetts, United States |
| Inga Britt & Arne Lundberg Research Foundation | Mölndal, Sweden, Vastra Gotaland |
| Japan Tobacco | Japan, Tokyo |
| K2 Investment | China, Hong Kong, Hong Kong Island |
| Morgan Stanley Canada Ltd | Canada, Ontario, Toronto |
| NBC Media Village Web | - |
| NDRC VentureLab | County Dublin, Dublin, Ireland |
| SB Players | Japan, Tokyo |
| SCM Specialty Finance Opportunities Fund | - |
| Second Alpha Partners | New York, New York, United States |
| Shenzhen Huashang Dingxin Equity Investment Fund Management | China, Guangdong, Shenzhen |
| Stride.VC | England, London, United Kingdom |
| SunnyBridge | Beijing, Beijing, China |
| Thursday Capital | California, Los Angeles, United States |
| Tudor Ventures | Boston, Massachusetts, United States |
| Windquest Group | Grand Rapids, Michigan, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CytoPherx | $34M | 04 Jan 2012 | Ann Arbor, Michigan, United States | ||
CytoPherx | $11M | 17 Jun 2010 | Ann Arbor, Michigan, United States | ||
Viamet Pharmaceuticals | $25M | 07 Jul 2009 | North Carolina, United States | ||
Aperion Biologics | $12M | 24 Jun 2008 | San Antonio, Texas, United States | ||
CytoPherx | $2M | 22 Oct 2007 | Ann Arbor, Michigan, United States | ||
Nanosphere | $5M | 06 Jan 2003 | Northbrook, Illinois, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CytoPherx | $34M | 04 Jan 2012 | Ann Arbor, Michigan, United States | ||
CytoPherx | $11M | 17 Jun 2010 | Ann Arbor, Michigan, United States | ||
Viamet Pharmaceuticals | $25M | 07 Jul 2009 | North Carolina, United States | ||
Aperion Biologics | $12M | 24 Jun 2008 | San Antonio, Texas, United States | ||
CytoPherx | $2M | 22 Oct 2007 | Ann Arbor, Michigan, United States | ||
Nanosphere | $5M | 06 Jan 2003 | Northbrook, Illinois, United States |
